OPKO Health (OPK) Competitors $1.51 -0.01 (-0.66%) (As of 10/31/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends OPK vs. PCRX, TARO, AVIR, ADCT, HRMY, FOLD, GERN, LGND, MYGN, and CLDXShould you be buying OPKO Health stock or one of its competitors? The main competitors of OPKO Health include Pacira BioSciences (PCRX), Taro Pharmaceutical Industries (TARO), Atea Pharmaceuticals (AVIR), ADC Therapeutics (ADCT), Harmony Biosciences (HRMY), Amicus Therapeutics (FOLD), Geron (GERN), Ligand Pharmaceuticals (LGND), Myriad Genetics (MYGN), and Celldex Therapeutics (CLDX). These companies are all part of the "medical" sector. OPKO Health vs. Pacira BioSciences Taro Pharmaceutical Industries Atea Pharmaceuticals ADC Therapeutics Harmony Biosciences Amicus Therapeutics Geron Ligand Pharmaceuticals Myriad Genetics Celldex Therapeutics Pacira BioSciences (NASDAQ:PCRX) and OPKO Health (NASDAQ:OPK) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation. Does the MarketBeat Community prefer PCRX or OPK? Pacira BioSciences received 318 more outperform votes than OPKO Health when rated by MarketBeat users. Likewise, 71.67% of users gave Pacira BioSciences an outperform vote while only 65.80% of users gave OPKO Health an outperform vote. CompanyUnderperformOutperformPacira BioSciencesOutperform Votes82271.67% Underperform Votes32528.33% OPKO HealthOutperform Votes50465.80% Underperform Votes26234.20% Do insiders & institutionals believe in PCRX or OPK? 99.7% of Pacira BioSciences shares are held by institutional investors. Comparatively, 64.6% of OPKO Health shares are held by institutional investors. 6.4% of Pacira BioSciences shares are held by insiders. Comparatively, 47.3% of OPKO Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Is PCRX or OPK more profitable? Pacira BioSciences has a net margin of 9.21% compared to OPKO Health's net margin of -33.79%. Pacira BioSciences' return on equity of 13.22% beat OPKO Health's return on equity.Company Net Margins Return on Equity Return on Assets Pacira BioSciences9.21% 13.22% 7.24% OPKO Health -33.79%-17.67%-12.07% Do analysts rate PCRX or OPK? Pacira BioSciences currently has a consensus target price of $24.20, suggesting a potential upside of 45.78%. OPKO Health has a consensus target price of $2.75, suggesting a potential upside of 82.12%. Given OPKO Health's stronger consensus rating and higher possible upside, analysts plainly believe OPKO Health is more favorable than Pacira BioSciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pacira BioSciences 2 Sell rating(s) 4 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.20OPKO Health 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to PCRX or OPK? In the previous week, Pacira BioSciences had 2 more articles in the media than OPKO Health. MarketBeat recorded 4 mentions for Pacira BioSciences and 2 mentions for OPKO Health. Pacira BioSciences' average media sentiment score of 0.90 beat OPKO Health's score of 0.70 indicating that Pacira BioSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pacira BioSciences 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OPKO Health 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility and risk, PCRX or OPK? Pacira BioSciences has a beta of 0.84, indicating that its stock price is 16% less volatile than the S&P 500. Comparatively, OPKO Health has a beta of 1.63, indicating that its stock price is 63% more volatile than the S&P 500. Which has stronger earnings and valuation, PCRX or OPK? Pacira BioSciences has higher earnings, but lower revenue than OPKO Health. OPKO Health is trading at a lower price-to-earnings ratio than Pacira BioSciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPacira BioSciences$690.31M1.12$41.96M$1.4311.61OPKO Health$716.37M1.47-$188.86M-$0.35-4.31 SummaryPacira BioSciences beats OPKO Health on 12 of the 18 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get OPKO Health News Delivered to You Automatically Sign up to receive the latest news and ratings for OPK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OPK vs. The Competition Export to ExcelMetricOPKO HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.05B$7.13B$5.37B$8.41BDividend YieldN/A8.77%5.23%4.20%P/E Ratio-4.5816.12131.9117.69Price / Sales1.47258.821,441.8380.21Price / CashN/A50.1639.1233.56Price / Book0.845.674.744.57Net Income-$188.86M$151.43M$115.66M$225.49M7 Day Performance7.86%-1.79%-0.88%-0.61%1 Month Performance1.34%5.94%3.59%1.50%1 Year Performance20.80%40.10%38.93%32.93% OPKO Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OPKOPKO Health4.5982 of 5 stars$1.51-0.7%$2.75+82.1%+23.6%$1.05B$716.37M-4.583,930Upcoming EarningsPCRXPacira BioSciences4.7616 of 5 stars$16.83-1.1%$24.20+43.8%-39.3%$776.37M$674.98M12.85720Upcoming EarningsNews CoverageTAROTaro Pharmaceutical Industries0.6089 of 5 stars$42.97flat$43.00+0.1%N/A$1.62B$629.18M29.841,554Analyst ForecastNegative NewsAVIRAtea Pharmaceuticals3.753 of 5 stars$3.35-0.9%$6.88+105.4%+5.8%$284.67M$351.37M-1.6070Short Interest ↓ADCTADC Therapeutics2.2586 of 5 stars$2.95+1.7%$9.00+205.6%+318.1%$239.23M$66.75M-1.15310Upcoming EarningsNews CoverageHRMYHarmony Biosciences4.8984 of 5 stars$34.50+1.3%$44.38+28.6%+71.5%$1.98B$582.02M17.69200Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageGap DownFOLDAmicus Therapeutics4.4376 of 5 stars$11.69-0.6%$17.13+46.5%+6.0%$3.46B$455.66M-29.97480Upcoming EarningsAnalyst DowngradeGERNGeron3.9632 of 5 stars$4.06+1.5%$6.94+71.0%+117.3%$2.41B$1.37M-11.28141Upcoming EarningsLGNDLigand Pharmaceuticals4.9234 of 5 stars$111.82+0.7%$134.40+20.2%+115.9%$2.04B$131.31M51.7780Upcoming EarningsAnalyst ForecastNews CoverageMYGNMyriad Genetics4.4915 of 5 stars$21.56-1.1%$28.91+34.1%+57.3%$1.96B$753.20M-11.912,700Upcoming EarningsPositive NewsCLDXCelldex Therapeutics2.0253 of 5 stars$26.95-4.2%$62.25+131.0%+16.0%$1.85B$8.30M-9.84160Upcoming EarningsAnalyst Forecast Related Companies and Tools Related Companies PCRX Competitors TARO Competitors AVIR Competitors ADCT Competitors HRMY Competitors FOLD Competitors GERN Competitors LGND Competitors MYGN Competitors CLDX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:OPK) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OPKO Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OPKO Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
